Yahoo
NYSE - Delayed Quote USD

Solventum Corporation (SOLV)

81.33 -2.23 (-2.67%)
At close: October 30 at 4:00:02 PM EDT
81.33 0.00 (0.00%)
After hours: October 30 at 4:02:56 PM EDT
Trade SOLV on Coinbase
Chart Range Bar
Loading chart for SOLV

What's happening with SOLV?

2h ago
Powered by Yahoo Scout

Solventum is approaching its fiscal third-quarter report with analysts expecting lower year-over-year revenue and earnings. Forecast models still point to a potential earnings beat, while recent FDA clearance expands the company’s advanced wound-care offering.

Powered by Yahoo Scout
  • Previous Close 83.56
  • Open 84.15
  • Bid 81.06 x 20000
  • Ask 81.12 x 20000
  • Day's Range 80.76 - 84.48
  • 52 Week Range 62.38 - 94.16
  • Volume 1,067,207
  • Avg. Volume 1,043,265
  • Market Cap (intraday) 13.844B
  • Beta (5Y Monthly) 0.70
  • PE Ratio (TTM) 9.95
  • EPS (TTM) 8.17
  • Earnings Date Nov 5, 2026
  • Forward Dividend & Yield -- (0.00%)
  • 1y Target Est 94.69
  • Morningstar Rating Rating available with Stock Picks access

Solventum Corporation, a healthcare company, develops, manufactures, and commercializes a portfolio of solutions to address critical customer and patient needs in the United States and internationally. It operates through three segments: Medsurg, Dental Solutions, and Health Information Systems. The Medsurg segment offers solutions, such as negative pressure wound therapy, advanced wound dressings, advanced skin care, synthetic tissue matrices, I.V. site management, sterilization assurance, temperature management, surgical supplies, medical tapes and wraps, stethoscopes, medical electrodes, and medical technologies for original equipment manufacturers. The Dental Solutions segment provides dental and orthodontic products, including brackets, aligners, restorative cements, and bonding agents to span the life of the tooth, and products for preventative dental care, direct and indirect restoration, and orthodontic needs. The Health Information Systems segment offers healthcare systems with software solutions comprising computer-assisted physician documentation, direct-to-bill and coding automation, classification methodologies, speech recognition, and data visualization platforms. The company sells its products and services through direct-to-consumer, distribution, key account management, inside sales, and e-commerce. Solventum Corporation was incorporated in 2023 and is headquartered in Eagan, Minnesota.

www.solventum.com

20,584

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Recent News

View More

Performance Overview

Trailing total returns as of 10/30/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

SOLV
2.64%
S&P 500 (^GSPC)
10.73%

1-Year Return

SOLV
17.39%
S&P 500 (^GSPC)
11.11%

3-Year Return

SOLV
10.68%
S&P 500 (^GSPC)
81.91%

5-Year Return

SOLV
10.68%
S&P 500 (^GSPC)
64.59%

Earnings Trends

View More

Earnings Per Share

GAAP
Normalized
GAAP
Normalized

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q2 FY26
Revenue 2.21B
Earnings 92M
Profit Margin 4.16%

Q3

FY25

Q4

FY25

Q1

FY26

Q2

FY26

0
500M
1B
2B
2B
20.0%
40.0%
60.0%

Analyst Insights

View More

Analyst Price Targets

71.00 Low
94.69 Average
81.33 Current
113.00 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell

Latest Rating

Date 9/14/2026
Analyst BTIG
Rating Action Reiterates
Rating Buy
Price Action Maintains
Price Target 95 -> 95

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    17.26%

  • Return on Assets (ttm)

    2.70%

  • Return on Equity (ttm)

    33.96%

  • Revenue (ttm)

    8.31B

  • Net Income Avi to Common (ttm)

    1.43B

  • Diluted EPS (ttm)

    8.17

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    403M

  • Total Debt/Equity (mrq)

    110.31%

  • Levered Free Cash Flow (ttm)

    489M

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: